Back to Search
Start Over
Vivet Therapeutics receives Orphan Drug Designation from European Commission for VTX-806
- Source :
- M2 Pharma. September 6, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PHARMA-September 6, 2024-Vivet Therapeutics receives Orphan Drug Designation from European Commission for VTX-806 (C)2024 M2 COMMUNICATIONS Clinical stage biotech company Vivet Therapeutics announced on Thursday that it has received [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.807448483